Hosted on MSN1mon
Indian drugmaker Anthem Biosciences files for $397 million IPOThat gives it the top spot globally in terms of proceeds and volumes, according to consultancy firm KPMG. Anthem, which began operations in 2007 and has two manufacturing facilities, is also going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results